Valsartan And Hydrochlorothiazide Tablet, Film Coated
FDA Label NDC 70771-1487

1 label section · Submitted to the FDA by Zydus Lifesciences Limited · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Valsartan And Hydrochlorothiazide (NDC 70771-1487). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

Valsartan and Hydrochlorothiazide Tablets USP, 80/12.5 mg

NDC 70771-1485-0 in bottle of 1000 tablets

1000 tablets

Rx only

80 mg/ 12.5 mg (1e3318d3 0dba 4f48 8bd1 0ce09cde403d 05)

80 mg/ 12.5 mg (1e3318d3 0dba 4f48 8bd1 0ce09cde403d 05)

Valsartan and Hydrochlorothiazide Tablets USP, 160/12.5 mg

NDC 70771-1486-0 in bottle of 1000 tablets

1000 tablets

Rx only

160 mg/ 12.5 mg (1e3318d3 0dba 4f48 8bd1 0ce09cde403d 06)

160 mg/ 12.5 mg (1e3318d3 0dba 4f48 8bd1 0ce09cde403d 06)

Valsartan and Hydrochlorothiazide Tablets USP, 160/25 mg

NDC 70771-1487-0 in bottle of 1000 tablets

1000 tablets

Rx only

160 mg/ 25 mg (1e3318d3 0dba 4f48 8bd1 0ce09cde403d 07)

160 mg/ 25 mg (1e3318d3 0dba 4f48 8bd1 0ce09cde403d 07)

Valsartan and Hydrochlorothiazide Tablets USP, 320/12.5 mg

NDC 70771-1488-0 in bottle of 1000 tablets

1000 tablets

Rx only

320 mg/ 12.5 mg (1e3318d3 0dba 4f48 8bd1 0ce09cde403d 08)

320 mg/ 12.5 mg (1e3318d3 0dba 4f48 8bd1 0ce09cde403d 08)

Valsartan and Hydrochlorothiazide Tablets USP, 320/25 mg

NDC 70771-1489-0 in bottle of 1000 tablets

1000 tablets

Rx only

320 mg/ 25 mg (1e3318d3 0dba 4f48 8bd1 0ce09cde403d 09)

320 mg/ 25 mg (1e3318d3 0dba 4f48 8bd1 0ce09cde403d 09)

* Please review the disclaimer below.